What is the future of cellular and immune therapies in myeloma?

Who are the most optimal candidates to receive immunotherapy?

What are the challenges of immunotherapy?

What are the risks associated with immunotherapy in myeloma?

What are myeloma targets?

What is cellular therapy? Is it the same as adoptive cell therapy?

What are antigens and neoantigens?

What are common side effects associated with immunotherapy?

What is meant by immune system status? How is it measured?

What is GVAX? How is GVAX being used in myeloma?

What is the role of the immune system?

How can a person improve their immune status?

What are tumor suppressor proteins?

Are plasma cells part of the immune system?

What is antigen escape?

What is the immune system?

Can a person with a compromised immune system develop a response to a cancer vaccine?

When is the best time to potentially use a myeloma vaccine?

What are the different kinds of myeloma vaccines being explored?

What is the difference between a vaccine that is personalized and a shared (off the shelf or allogeneic) vaccine?

What are cancer vaccines and how do they work? What side effects are being seen with myeloma vaccines? Have any cancer vaccines been FDA approved?

How are vaccines made? What are vaccine adjuvants (immune stimulators)?